Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
lomustine (1 trial)
pembrolizumab (keytruda) (1 trial)
temozolomide (temodar) (1 trial)
Astrocytoma (Phase 2)
Brain Neoplasms (Phase 1)
Carcinoma (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Renal Cell (Phase 1)
Glioblastoma (Phase 2)
Neoplasm Metastasis (Phase 1)
Trials (3 total)
Trial APIs (3 total)